Inmune Bio, Inc. - COM (INMB)

Historical Portfolio Holders from Q1 2019 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	2.71 M	$31.9 M	+$4.84 M	41.1 K	524 K	$11.75	48
2023 Q4	2.22 M	$25 M	+$1.92 M	298 K	614 K	$11.26	44
2023 Q3	2.06 M	$14 M	+$742 K	308 K	249 K	$6.77	34
2023 Q2	2 M	$18.2 M	+$1.89 M	341 K	366 K	$9.08	30
2023 Q1	1.8 M	$11.6 M	+$1.1 M	13.6 K	103 K	$6.46	30
2022 Q4	1.64 M	$10.4 M	-$729 K	102 K	333 K	$6.34	30
2022 Q3	1.91 M	$11.9 M	-$743 K	122 K	313 K	$6.20	28
2022 Q2	1.97 M	$17.2 M	-$2.2 M	0	433 K	$8.84	32
2022 Q1	2.25 M	$18.9 M	-$2.11 M	208 K	243 K	$8.42	29
2021 Q4	2.47 M	$25.2 M	+$5.01 M	390 K	461 K	$10.20	40
2021 Q3	1.91 M	$37.1 M	+$3.94 M	2.65 M	2.7 M	$19.42	38
2021 Q2	1.73 M	$30.4 M	+$8.49 M	894 K	973 K	$17.57	38
2021 Q1	1.31 M	$15.5 M	+$5.45 M			$11.88	31
2020 Q4	792 K	$13.6 M	+$1.19 M			$17.20	23
2020 Q3	992 K	$10.2 M	+$6.46 M			$10.30	26
2020 Q2	359 K	$1.88 M	+$107 K			$5.17	11
2020 Q1	341 K	$1.14 M	+$199 K			$3.33	8
2019 Q4	282 K	$1.64 M	+$40.4 K			$5.80	9
2019 Q3	275 K	$1.62 M	+$1.39 M			$5.90	9
2019 Q2	35.7 K	$346 K	-$68.2 K			$9.85	6
2019 Q1	44.7 K	$350 K	+$350 K			$7.83	3